Role of apolipoprotein A-I in protecting against endotoxin toxicity

Acta Biochimica et Biophysica Sinica

Volumn 36, Issue 6, 2004, Pages 419-424

  Ma, Juan ^a   Liao, Xue Ling ^a   Lou, Bin ^a   Man Ping, W U ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Apolipoprotein I; FITC lipopolysaccharide (FITC LPS); L 929 cells; Lipopolysaccharide (LPS); Macrophages

Indexed keywords

APOLIPOPROTEIN A1; CYTOKINE; ENDOTOXIN; HIGH DENSITY LIPOPROTEIN; LIPOPOLYSACCHARIDE; NITROBLUE TETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROTECTION; CELL STRAIN L 929; CONTROLLED STUDY; CYTOKINE RELEASE; FLUORESCENCE; INCUBATION TIME; INFRARED SPECTROSCOPY; MACROPHAGE; MORTALITY; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PLASMA; PROTEIN BINDING; PROTEIN FUNCTION; SURVIVAL TIME;

ANIMALIA;

EID: 4143096133     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: 10.1093/abbs/36.6.419     Document Type: Article

References (19)

1. Ulevitch RJ. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv Immunol, 1993, 53: 267-289
2. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS et al. Structure and function of lipopolysaccharide binding protein. Science, 1990, 249(4975): 1429-1431
3. de Haas CJ, Poppelier MJ, van Kessel KP, van Strijp JA. Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide. Infect Immun, 2000, 68(9): 4954-4960
4. Levels JH, Abraham PR, van den Ende A, van Deventer SJ. Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun, 2001, 69(5): 2821-2828
5. Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G et al. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature, 1997, 389(6652): 742-745
6. Brandenburg K, Jurgens G, Andra J, Lindner B, Koch MH, Blume A, Garidel P. Biophysical characterization of the interaction of high-density lipoprotein (HDL) with endotoxins. Eur J Biochem, 2002, 269(23): 5972-5981
7. van Leeuwen HJ, van Beek AP, Dallinga-Thie GM, van Strijp JA, Verhoef J, van Kessel KP. The role of high density lipoprotein in sepsis. Nertherlands J Med, 2001, 59(3): 102-110
8. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA, 1993, 90(24): 12040-12044
9. Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: Metabolism, actions, and therapeutic applications. Shock, 2004, 21(3): 210-221
10. Zhang H, Wu MP, Lou B, Chen PF. Role of high density lipoprotein in protecting against endotoxin toxity. Fudan Univ J Med Sci, 2003, 30(5): 474-476
11. Parker TS, Levine DM, Chang JC, Laxer J, Coffin CC, Rubin AL. Reconstituted high-density lipoprotein neutralizes Gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun, 1995, 63(1): 253-258
12. Massamiri T, Tobias PS, Curtiss LK. Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: Role of apolipoprotein A-I. J Lipid Res, 1997, 38(3): 516-525
13. Park CT, Wright SD. Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins. J Biol Chem, 1996, 271(30): 18054-18060
14. Ba DN ed. Contemporary Immunological Technology and Application, Beijing: Peking University Medical Press, 1998, 262-263
15. Liu YH, Ding SP, Lin AH, Fang JG, Shi SP. The protective effects of different polar fractions from radix isatids on endotoxin challenged mice. Acta Univ Med Tingji, 2001, 30(3): 272-273
16. Cavaillon JM, Fitting C, Haeffner-Cavaillon N, Kirsch SJ, Warren HS. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun, 1990, 58(7): 2375-2382
17. Imai T, Fujita T, Yamazaki Y. Beneficial effects of apolipoprotein A-I on endotoxemia. Surg Today, 2003, 33(9): 684-687
18. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in neutralization of LPS. J Exp Med, 1994, 180(3): 1025-1035
19. Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun, 1993, 61(12): 5140-5146